Ledger.Open graph →
SEC Form D · filed December 20, 2011

ReVision Therapeutics, Inc

Offering
$5.0M
Sold
$500K
Exemption
—
Industry
Biotechnology
Location
La Jolla, CA
Type
—

People & firms on this filing (7)

Douglas Downs · La Jolla, CAExecDavid Weber · Menlo Park, CADirectorJay Lichter, Ph.D · La Jolla, CAExec · DirectorDouglas Downs · La Jolla, CAExecNathan Mata · La Jolla, CAExecKevin Kinsella · San Diego, CADirectorDavid Weber · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗